Syndax Pharmaceuticals, Inc. (SNDX)
Nasdaq: SNDX · Pharmaceutical Preparations · New York, NY · filing with the SEC since 2007
Who runs Syndax Pharmaceuticals, Inc.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Metzger Michael A
Chief Executive Officer. First filing Mar 2016, latest Jul 9, 2026, 22 filings in all.
Officers reporting now
4
of 10 people with a filing in the last fifteen months
Directors reporting now
6
28 people on the record since 2016
Officerssales are open-market, Nov 12, 2025 to Nov 12, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Ondrey Aaron | Chief Financial Officer | Nov 2026 | Nov 12, 2026 | none |
| Metzger Michael A | Chief Executive Officer | Mar 2016 | Jul 9, 2026 | 4 · $1.4M |
| Botwood Nicholas A.J. | Head of R&D, CMO | May 2025 | Jun 12, 2026 | 2 · $1.2M |
| Goldan Keith A. | Chief Financial Officer | Jun 2022 | Jun 2, 2026 | 3 · $100,000 |
Directorssales are open-market, Nov 12, 2025 to Nov 12, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Podlesak Dennis | director | Mar 2016 | Oct 30, 2026 | 1 · $100,000 |
| Huber Martin H. Jr. | director | Sep 2021 | Feb 6, 2026 | none |
| Jarrett Jennifer | director | Sep 2018 | Feb 6, 2026 | none |
| Katkin Keith | director | Mar 2017 | Feb 6, 2026 | none |
| Legault Pierre | director | Jan 2017 | Feb 6, 2026 | none |
| Rizo Aleksandra | director | May 2024 | Feb 6, 2026 | none |
Earlier names on the record38, newest filing first
Gallagher Neil · officer · last filing Feb 2025Meury William · director · last filing Feb 2025Morrison Briggs · officer · last filing Feb 2024Ordentlich Peter · officer · last filing Feb 2023Madigan Catherine · officer · last filing Feb 2023Nolte Alexander · officer · last filing Feb 2023Sabus Steve M · officer · last filing Dec 2022Meyers Michael L. · officer · last filing Feb 2022Egros Fabrice · director · last filing Feb 2022Karydas Daphne · officer · last filing Feb 2021Shea Richard P · officer · last filing Feb 2020Biotechnology Value Fund II LP · other · last filing Jun 2018Biotechnology Value Fund L P · other · last filing Jun 2018Biotechnology Value Trading Fund Os LP · other · last filing Jun 2018Bvf Inc/il · 10% owner · last filing Jun 2018Bvf Partners L P/il · 10% owner · last filing Jun 2018Bvf Partners Os Ltd. · other · last filing Jun 2018Lampert Mark N · 10% owner · last filing Jun 2018Chen Henry · director · last filing May 2018Evnin Luke · director · last filing May 2018Sledge George W. Jr. · director · last filing May 2017Royston Ivor · director · last filing Mar 2017Kamdar Kim P. · director · last filing Nov 2016Foley Todd · 10% owner · last filing Mar 2016Gadicke Ansbert · 10% owner · last filing Mar 2016Kailian Vaughn M · 10% owner · last filing Mar 2016Mpm Asset Management Investors Bv4 LLC · 10% owner · last filing Mar 2016Mpm Bioventures IV Gmbh & Co. Beteiligungs Kg · 10% owner · last filing Mar 2016Mpm Bioventures IV Gp LLC · 10% owner · last filing Mar 2016Mpm Bioventures IV LLC · 10% owner · last filing Mar 2016Mpm Bioventures IV Qp LP · 10% owner · last filing Mar 2016Mpm Bioventures IV Strategic Fund, L.P. · 10% owner · last filing Mar 2016Scopa James Paul · 10% owner · last filing Mar 2016Dp Vi Associates, L.P. · director · last filing Mar 2016Blair James C · 10% owner · last filing Mar 2016Domain Partners Vi, L.P. · 10% owner · last filing Mar 2016Domain Partners Viii, L.P. · 10% owner · last filing Mar 2016Shaw Allan · officer · last filing Mar 2016
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.